Home › Funds › Novo Holdings A/S › AVLN

Novo Holdings A/S position in AVLN

AVALYN PHARMACEUTICALS INC · Health Care

Novo Holdings A/S reported holding 3,449,191 shares of AVLN (AVALYN PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$98.3M, representing 6.60% of its reported portfolio and ranking #5 among its reported holdings. Novo Holdings A/S has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)3.45M sh
Reported value held$98.27M
Portfolio Weight6.60%
First reportedQ2 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Novo Holdings A/S's AVLN position evolved

Novo Holdings A/S first disclosed a stake in AVLN in Q2 2026 at 3,883,289 shares (US$127.8M). Across 2 filings, Novo Holdings A/S increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,449,191 shares valued at US$98.3M — a reduction of -434,098 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 3.88M $127.84M New
Q3 2026 3.45M $98.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVLN and 13F data

AVLN (AVALYN PHARMACEUTICALS INC) is a Health Care company. 114 other funds we track also report a position in AVLN — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$94.3M), PERCEPTIVE ADVISORS LLC (US$76.2M), MONTANOVA CAPITAL, LLC (US$71.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVLN

All AVLN fund holders →

FAQ

How long has Novo Holdings A/S held AVLN?

Novo Holdings A/S has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Novo Holdings A/S's current position in AVLN?

As of Q3 2026, Novo Holdings A/S holds 3.45M shares of AVLN (AVALYN PHARMACEUTICALS INC), valued at $98.27M, representing 6.60% of its reported portfolio and ranking #5.

Has Novo Holdings A/S been buying or selling AVLN?

In the latest 13F filing (Q3 2026), Novo Holdings A/S reduced its position in AVLN.

Which other funds hold AVLN?

Other major institutional holders of AVLN include SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, MONTANOVA CAPITAL, LLC, among 114 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.